Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DECKER

Showing results (681-690 of 718) with videos related to

Pageof 72
Sort By:
Genetic Epidemiology|January 3, 2013
Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studiesKyle M Walsh, Erik Anderson, Helen M Hansen, et al.
Neuro-Oncology Advances|June 16, 2023
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E Conage-Pough, Sylwia A Stopka, Ju-Hee Oh, et al.
Neuro-Oncology Advances|March 19, 2026
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Molecular Cancer Therapeutics|July 5, 2018
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain BarrierMinjee Kim, Daniel J Ma, David Calligaris, et al.
Neuro-Oncology|April 15, 2025
The novel brain penetrant ATM inhibitor WSD0628 provides robust radiosensitization of brain tumor patient derived xenograftsZhiyi Xue, Ann C Mladek, Sneha Rathi, et al.
Neuro-Oncology|July 7, 2021
Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin-a novel tumor checkpoint controller targeting microtubulesDanielle M Burgenske, Surabhi Talele, Jenny L Pokorny, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2023
CYP eicosanoid pathway mediates colon cancer-promoting effects of dietary linoleic acidJianan Zhang, Jun Yang, Caroline Duval, et al.
Acta Neuropathologica|March 4, 2017
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERTMelike Pekmezci, Terri Rice, Annette M Molinaro, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2023
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk PatientsSuzette J Bielinski, Licy L Yanes Cardozo, Paul Y Takahashi, et al.
World Journal for Pediatric & Congenital Heart Surgery|January 7, 2021
Heart Transplantation for Pediatric and Congenital Cardiac Disease: A Comparison of Two Eras over 23 Years and 188 Transplants at a Single InstitutionGenevieve C Tuite, James A Quintessenza, Alfred Asante-Korang, et al.
Pageof 72

Showing results (681-690 of 718) with videos related to

Sort By:
Pageof 72
Genetic Epidemiology|January 3, 2013
Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studiesKyle M Walsh, Erik Anderson, Helen M Hansen, et al.
Neuro-Oncology Advances|June 16, 2023
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E Conage-Pough, Sylwia A Stopka, Ju-Hee Oh, et al.
Neuro-Oncology Advances|March 19, 2026
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoringCecile Riviere-Cazaux, Yuta Suzuki, Zain Kizilbash, et al.
Molecular Cancer Therapeutics|July 5, 2018
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain BarrierMinjee Kim, Daniel J Ma, David Calligaris, et al.
Neuro-Oncology|April 15, 2025
The novel brain penetrant ATM inhibitor WSD0628 provides robust radiosensitization of brain tumor patient derived xenograftsZhiyi Xue, Ann C Mladek, Sneha Rathi, et al.
Neuro-Oncology|July 7, 2021
Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin-a novel tumor checkpoint controller targeting microtubulesDanielle M Burgenske, Surabhi Talele, Jenny L Pokorny, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2023
CYP eicosanoid pathway mediates colon cancer-promoting effects of dietary linoleic acidJianan Zhang, Jun Yang, Caroline Duval, et al.
Acta Neuropathologica|March 4, 2017
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERTMelike Pekmezci, Terri Rice, Annette M Molinaro, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2023
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk PatientsSuzette J Bielinski, Licy L Yanes Cardozo, Paul Y Takahashi, et al.
World Journal for Pediatric & Congenital Heart Surgery|January 7, 2021
Heart Transplantation for Pediatric and Congenital Cardiac Disease: A Comparison of Two Eras over 23 Years and 188 Transplants at a Single InstitutionGenevieve C Tuite, James A Quintessenza, Alfred Asante-Korang, et al.
Pageof 72